PF-05280014
B3271002
Phase 3 mab completed
Quick answer
PF-05280014 for Metastatic Breast Cancer is a Phase 3 program (mab) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Metastatic Breast Cancer
- Phase
- Phase 3
- Modality
- mab
- Status
- completed